Viewing Study NCT01302860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2026-02-01 @ 11:44 PM
Study NCT ID: NCT01302860
Status: COMPLETED
Last Update Posted: 2017-03-29
First Post: 2011-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cryopyrin-associated Periodic Syndromes View
None Familial Cold Autoinflammatory Syndrome View
None Muckle-Wells Syndrome View
None Neonatal Onset Multisystem Inflammatory Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Cryopyrin-associated periodic syndromes (CAPS) View
None Familial Cold Autoinflammatory Syndrome (FCAS) View
None Muckle-Wells Syndrome (MWS) or Neonatal Onset Multisystem Inflammatory Disease (NOMID) View
None children View
None systemic autoinflammatory disease View
None CIAS-1 gene View
None NALP-3 View
None NLRP3 View
None ACZ885 View
None Ilaris View
None human monoclonal anti-human interleukin-1 beta (IL-beta) View
None antibody View
None autosomal dominant View
None familial autoinflammatory syndrome View